A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 29
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ZYM
Long Form : zymosan
No. Year Title Co-occurring Abbreviation
2020 Zymosan promotes proliferation, Candida albicans adhesion and IL-1beta production of oral squamous cell carcinoma in vitro. CLIA, HNSCC, OSCC
2019 NF-kappaB activation mediates LPS-or zymosan-induced hypotension and inflammation reversed by BAY61-3606, a selective Syk inhibitor, in rat models of septic and non-septic shock. IkappaB, LPS, NF-kappaB, Syk
2019 Tofacitinib facilitates the expansion of myeloid-derived suppressor cells and ameliorates interstitial lung disease in SKG mice. BMDC, MDSCs, RA-ILD
2018 The role of Syk/IB-alpha/NF-B pathway activation in the reversal effect of BAY 61-3606, a selective Syk inhibitor, on hypotension and inflammation in a rat model of zymosan-induced non-septic shock. COX, IB, iNOS, MPO, NF-B, Syk, TNF
2016 [The effects of agmatine on acute peritoneal inflammatory injury and neutrophil infiltration induced by zymosan in mice]. Agm, ELISA, IL-6, KC, MIP-2, PBS, PLF, PMN, TNF-alpha
2015 Galactomannan and Zymosan Block the Epinephrine-Induced Particle Transport in Tracheal Epithelium. GM, PTV, ROS
2014 Agmatine protects against zymosan-induced acute lung injury in mice by inhibiting NF-kappaB-mediated inflammatory response. ALI, CNS, NF
2014 CMV specific cytokine release assay in whole blood is optimized by combining synthetic CMV peptides and toll like receptor agonists. Bro, CMV, fla, HC, IGRAs, LOX, LPS, LTA, PGN
2014 Involvement of brain cytokines in zymosan-induced febrile response. CNS, IL-1beta, LPS, MnPO, TNF-alpha
10  2013 N-acetylcysteine administration is associated with reduced activation of NF-kB and preserves lung dendritic cells function in a zymosan-induced generalized inflammation model. DCs, NAC, ZIGI
11  2013 Use of data mining to determine changes in the gene expression profiles of rat embryos following prenatal exposure to inflammatory stimulants. LPS
12  2012 Treatment with Fms-like tyrosine kinase 3 ligand reverses lung dendritic cell immunoparalysis and ameliorates zymosan-induced secondary lung injury in mice. DC, Flt3L, i.p, IL, MHC, MODS, s.c
13  2011 Fungal cell wall agents suppress the innate inflammatory cytokine responses of human peripheral blood mononuclear cells challenged with lipopolysaccharide in vitro. CHT, FCWAs, LPS, MR, PBMC
14  2011 [The protective effects of agmatine in zymosan induced acute lung injury in mice]. Agm, ALI, ELISA, MPO, NF-cB p65, NO, TNF-a
15  2010 Attenuation of toll-like receptor 2-mediated innate immune response in patients with alcoholic chronic liver disease. ACLD, IL-10, LBP, LP, LPS, PBM, TLR, TNF-alpha
16  2010 Effects of immunomodulatory and organism-associated molecules on the permeability of an in vitro blood-brain barrier model to amphotericin B and fluconazole. AmB, BBB, CNS, DAMB, DEX, IL-1beta, L-AMB, LPS, LTA, TEER, TNF-alpha, ZO-1
17  2009 Identification of the molecules involved in zebra mussel (Dreissena polymorpha) hemocytes host defense. ESTs, LPS, PGN, qPCR, SSH
18  2007 Matrilin-like molecules produced by circulating hemocytes of the zebra mussel (Dreissena polymorpha) upon stimulation. LPS, PGN, SSH, VWA
19  2004 Selective macrophage suppression during sepsis. CLP, LPS, LTA
20  2003 Effects of antiinflammatory drugs on arthritic cartilage: a high-frequency quantitative ultrasound study in rats. DEX, IRC, NPX, US
21  2002 Thermal response to zymosan: the differential role of complement. CVF, i.p, i.v, PFS
22  1999 Inflammatory and immunopharmacological activities of meta-periodate oxidized zymosan. ---
23  1995 Inactivation of (1-->3)-beta-D-glucan in mice. GRN, LPS, TNF-alpha
24  1995 Structure-activity relationship of (1-->3)-beta-D-glucans in the induction of cytokine production from macrophages, in vitro. LAM, LPS, TNF-alpha
25  1995 The influence of age and sex on phagocyte chemiluminescence. CL, PMA, PMNL, SOZ
26  1990 Latent inhibition of granulocyte function by cyclosporine A. CL, CsA, HLE, PMA
27  1990 Reduced activity of DAF on complement enzymes bound to alternative pathway activators. Similarity with Factor H. DAF, Er
28  1989 Release of colony-stimulating activity by resting and activated monocytes, T cells and B cells. CM, Con A, GM-CSA, LPS, PHA, PWM
29  1983 Determination of alternate pathway complement kinetics by electron spin resonance spectroscopy. DMPO, ESR, Op-zym